RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosteroneNo FDA-approved oral therapies currently exist for this un ...

If your libido’s dried up and your energy levels are dipping, it could be a hormone problem. Here's how to find out if it is.

Male Hypogonadism: Overview This article was reviewed by Peter J. Stahl, MD. The medical term for testosterone deficiency that causes symptoms is male hypogonadism. Testosterone is one of the most ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

So how could I explain the fatigue, dwindling libido, loss of focus, and other symptoms? I wondered if I might be in the clutches of something else: male menopause. Also known as late-onset ...

Testosterone treatment in middle-aged and older men with hypogonadism does not appear to reduce the risk for clinical fracture, and in fact, in an unexpected finding, significantly increases the ...

Testosterone treatment in men who have hypogonadism due to pituitary or testicular disease has been reported to improve many measures of their bone structure and quality. Studies have shown that ...

Summary This latest Pharmaceutical and Healthcare disease pipeline guide Secondary (Hypogonadotropic) Hypogonadism - Drugs In Development, 2022, provides an overview of the Secondary ...

Hypogonadism is most common in men aged above 60. In countries like Japan, China, and the U.S. there is surge in demand for male hypogonadism treatments, owing to increase in geriatric population ...

Hypogonadism was defined as a testosterone concentration below the lower limit of normal levels. The primary outcome of the study was COVID-19 hospitalization.

The study, "Association of Male Hypogonadism with Risk of Hospitalization from COVID-19," was published online Sept. 2 in JAMA Network Open.

Low testosterone in men is a widespread clinical problem linked to obesity, high blood pressure and Type 2 diabetes. Nearly 39 percent of the world’s male population aged 45 and over have hypogonadism ...